Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease

INTRODUCTION: Deep remission, defined as clinical remission with mucosal healing (MH), with anti-tumor necrosis factor (TNF)-α agents is a new target for therapy in Crohn’s disease (CD). Provided that the efficacy of infliximab (IFX) for induction of MH in CD has been demonstrated, there are much le...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Prz Gastroenterol
Hoofdauteurs: Szymanska, Edyta, Dadalski, Maciej, Grajkowska, Wieslawa, Szymanska, Sylwia, Pronicki, Maciej, Kierkus, Jaroslaw
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Termedia Publishing House 2016
Onderwerpen:
Original Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5360663/
https://ncbi.nlm.nih.gov/pubmed/28337236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/pg.2016.64746
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items